ICD-10-CM Billable Code

T44.1X4

Poisoning by other parasympathomimetics [cholinergics], undetermined

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by other parasympathomimetics, specifically cholinergics, is a medical condition resulting from the excessive intake or exposure to substances that stimulate the parasympathetic nervous system. These substances, known as cholinergics, mimic the action of acetylcholine, a neurotransmitter involved in many bodily functions. When they are used improperly or in overdose, they can cause a range of symptoms due to overstimulation of parasympathetic nerves, leading to a medical situation that requires prompt identification and management.

Causes & Symptoms

Clinical Causes: Accidental ingestion of cholinergic pesticides or chemicals Overuse or overdose of medications containing parasympathomimetics, such as certain anticholinesterase drugs Exposure to environmental sources of cholinergic compounds Intentional poisoning or misuse of cholinergic agents Medical errors during the administration of cholinergic drugs

Key Symptoms: Salivation (excessive drooling) Lacrimation (tearing or watery eyes) Urination difficulties, including increased frequency Gastrointestinal symptoms like nausea, vomiting, abdominal cramps, or diarrhea Bradycardia (slow heart rate) Respiratory distress, including wheezing and difficulty breathing Muscle weakness or twitching Dizziness or confusion Constricted pupils (miosis) Seizures in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive medical history and physical examination, focusing on exposure history and symptom presentation. Healthcare providers may perform laboratory tests such as blood tests to identify cholinergic agents or assess organ function. Specific tests to measure cholinesterase enzyme activity can help confirm poisoning caused by cholinergic agents. Imaging or additional procedures may be necessary if there are complications or if the source of poisoning is uncertain. Early diagnosis is critical for effective management.

Treatment Protocols: Treatment strategies aim to reverse the effects of cholinergic poisoning and may include the following interventions: - **Immediate decontamination:** Removing the person from the source of exposure and washing skin or eyes if contamination is external. - **Supportive care:** Maintaining airway, breathing, and circulation; administering oxygen; and monitoring vital signs. - **Medication:** Administering antidotes such as atropine, which blocks the effects of excess acetylcholine at receptor sites. - **Pralidoxime:** Used in some cases to reactivate cholinesterase enzymes, particularly in organophosphate poisoning. - **Monitoring and managing complications:** Including seizure control and respiratory support as needed. It is crucial for individuals suspected of cholinergic poisoning to seek immediate medical attention. Healthcare providers will tailor treatment based on the severity of symptoms and the specific agent involved.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T44.1X4 a billable ICD-10 code?
Yes, T44.1X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T44.1X4?
Clinical documentation must specify the nature of Poisoning by other parasympathomimetics [cholinergics], undetermined and any associated comorbidities for accurate reporting.

Cite this Clinical Reference